AzTrials
AzTrials

Common Mental DisordersNCT03322839

Evaluating the Effectiveness of Multifaceted Implementation Strategies for Implementing a Guideline for the Prevention of Common Mental Disorders at the Workplace in Schools

A study testing Multifaceted implementation strategies and Single implementation strategy in people with Common Mental Disorders, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Given today's high prevalence of common mental disorders and related sick leave among teachers an urgent need exists for a more sustainable working life for this professional group. One way of doing this is by improving schools' social and organizational risk management. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Common Mental Disorders
What is being tested?
Multifaceted implementation strategies and Single implementation strategy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
732 participants
Where
1 siteSweden
Study dates
12 Sep 2017to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • all individuals who are employed by the participating schools

Who cannot join

  • individuals employed by the participating municipalities and not by the participating schools, for example cleaning personal. Individuals on sick-leave

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Unit for Intervention and Implementation Research for Worker Health, Institute for Environmental Medicine, Karolinska Institute

    Stockholm, 171 77

Other trials in Sweden

About this study

Official title: Implementing the Swedish Guideline for the Prevention of Common Mental Disorders at the Workplace in Schools: Study Protocol of a Cluster Randomized Controlled Trial Using Multifaceted Implementation Strategies

Given today's high prevalence of common mental disorders and related sick leave among teachers an urgent need exists for a more sustainable working life for this professional group. One way of doing this is by improving schools' social and organizational risk management. Recent reports have shown that many schools in Sweden however lack a structured approach to the management of social and organizational risks. In 2015, we launched the first Swedish occupational health guideline to support a structured prevention of social and organizational risks at the workplace with the aim of preventing common mental disorders. The long-term goal of this study is to support the implementation of this guideline within schools in order to improve social and organizational risk management and in doing so reduce risk factors for mental ill-health and related sick days. The objective of the study is to fill the current research-to-practice gap by conducting a cluster-randomized controlled trial that compares the effectiveness of two implementation strategies for implementing the guideline in schools. The strategies that will be compared are training (ARM 1) versus training in combination with implementation teams and workshops (ARM 2). Our hypothesis for the study is that schools that receive support in implementing the guideline through combined strategies are more responsive to working in a structured and systematic manner with the management of social and organizational risks than schools that only receive training. The trial will be conducted in 20 primary schools in two municipalities in Sweden. All schools have agreed to participate. The primary outcomes are adherence to the guideline (implementation effectiveness) and self-reported exhaustion among schools personnel (intervention effectiveness); the secondary outcomes are risk factors for mental ill-health and absenteeism. Data will be collected at baseline, 6, 12 and 24 months by mixed methods (i.e. survey, focus-group interviews, observation, and register-data).

Being tested
Multifaceted implementation strategies, Single implementation strategy
Keywords
Guideline-adherence, Implementation, Implementation-strategies, Randomized-controlled-trial, Organisational risk-factors, Schools, Social risk-factors

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multifaceted implementation strategiesBehavioural

    The school-management will participate in a one-day training aimed at providing knowledge and skills related the recommendations of the guideline for the prevention of common mental disorders at the workplace.In addition every intervention school will form an implementation team that is responsible for the implementation of the guideline. The implementation team will comprise of approximately 3-5 individuals with experience in the field of social and organizational work environment, for example school-management and occupational health and safety representative. The implementation teams will participate in 4-5 workshops aimed at supporting the implementation process. Intervention schools within the same municipality will participate in the same workshop in order to promote peer-support.

  • Single implementation strategyBehavioural

    The school-management will participate in a one-day training aimed at providing knowledge and skills related to the recommendations of the guideline for the prevention of common mental disorders at the workplace

Study groups in NCT03322839
Study groupRoleWhat they receive
Multifaceted implementation strategiesExperimentalThe school-management will participate in a one-day training. In addition each intervention school will form an implementation team that is responsible for the implementation of the guideline within their school. The implementation teams will participate in 4-5 workshops in order to support the implementation process.
Receives: Behavioral: Multifaceted implementation strategies
Single implementation strategyActive comparatorThe control-schools will only receive training to the school-management.
Receives: Behavioral: Single implementation strategy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Guideline adherence (implementation effectiveness)

    Change from baseline in adherence to the recommendations of the guideline during 6, 12 and 24 months follow-up period. We will use a questionnaire directed at the school management and a questionnaire directed at the school personnel. The questionnaires contain statements related to the recommendations in the guideline, such as "at our school we have clear and practical policies for preventing mental ill-health among our employees".

    Measured: At baseline and 6, 12 and 24 months after baseline

  2. Exhaustion (intervention effectiveness)

    Change from baseline in personnel's self-reported exhaustion during 6, 12 and 24 months follow. We hypothesize that adherence to the recommendations of the guideline will affect school personnel's self-reported exhaustion assessed with the Oldenburg Burnout Inventory (response format 1-4).

    Measured: At baseline and 6, 12 and 24 months after baseline

Secondary outcomes (30)
  1. Psychosocial safety climate

    Change from baseline in self-reported psychosocial safety climate as assessed by the 11-items of the Psychosocial Safety Climate Scale (response format 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  2. Job demands

    Change from baseline in self-reported job-demands as assessed by 11 items of the Copenhagen Psychosocial Questionnaire (response form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  3. Influence at work

    Change from baseline in self-reported influence at work as assessed by 4 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  4. Social support colleagues

    Change from baseline in self-reported social support as assessed by 3 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  5. Possibilities for development

    Change from baseline in self-reported possibilities for development as assessed by 4 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  6. Commitment to the workplace

    Change from baseline in self-reported commitment as assessed by 3 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  7. Social support superior

    Change from baseline in self-reported social support from superior as assessed by 3 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  8. Work engagement

    Change from baseline in self-reported engagement as assessed by 3 items of the Utrecht Work Engagement Scale (response-form 1-7)

    Measured: At baseline and 6, 12 and 24 months after baseline

  9. Self-perceived health

    Change from baseline in self-perceived health as assessed with a single question (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  10. Self-reported stress

    Change from baseline in self-reported stress as assessed with a single question (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  11. Work-family conflict

    Change from baseline in self-reported work-family conflict as assessed with 4 items of the Copenhagen Psychosocial Questionnaire (response-form 1-4)

    Measured: At baseline and 6, 12 and 24 months after baseline

  12. Recovery

    Change from baseline in self-reported recovery as assessed with 1 item (response-form 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  13. Work performance impairment due to health problems

    Change from baseline in work performance as assessed by a question based on one item from the Work productivity Activity impairment - General Health Questionnaire (response format 0-10)

    Measured: At baseline and 6, 12 and 24 months after baseline

  14. Work performance impairment due to problems in the work environment

    Change from baseline in work performance as assessed by a question based on one item from the Work Productivity Activity Impairment - General Health Questionnaire (response format from 0-10)

    Measured: At baseline and 6, 12 and 24 months after baseline

  15. Self-reported sickness absenteeism

    Change from baseline in self-reported sickness absenteeism as assessed by 2 items

    Measured: At baseline and 6, 12 and 24 months after baseline

  16. Registered sickness absenteeism

    Change in total sick-leave due to common mental disorders in days, register data (sickness benefit and disability pension).

    Measured: 12 months prior to baseline, and during 24 months after baseline

  17. Recognition (reward)

    Change from baseline self-reported collaboration and leadership as assessed by 3-items of Copenhagen Psychosocial Questionnaire (response-format 1-5)

    Measured: At baseline and 6, 12 and 24 months after baseline

  18. Self-reported stress (SMS)

    Change from baseline in self-reported stress as assessed by one item sent by text-message by mobile-phone

    Measured: Measured every 4th week over 12 months from baseline

  19. Process evaluation data

    Process data will be collected over the 24 months. This data will be assessed by focus-group interviews.

    Measured: Assessed during the 24 month study period.

  20. Process evaluation data

    Process data will be collected over the 24 months. This data will be assessed by questionnaires

    Measured: Assessed during the 24 month study period.

  21. Process evaluation data

    Process data will be collected over the 24 months. This data will be assessed by observation

    Measured: Assessed during the 24 month study period.

  22. Process evaluation data

    Process data will be collected over the 24 months. This data will be assessed by documentation.

    Measured: Assessed during the 24 month study period.

  23. Barriers

    Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by focus-group interviews

    Measured: Assessed during the 24 month study period

  24. Barriers

    Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by questionnaires

    Measured: Assessed during the 24 month study period

  25. Barriers

    Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by observation

    Measured: Assessed during the 24 month study period

  26. Barriers

    Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by documentation.

    Measured: Assessed during the 24 month study period

  27. Facilitators

    Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by focus-group interviews

    Measured: Assessed during the 24 month study period

  28. Facilitators

    Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by questionnaires

    Measured: Assessed during the 24 month study period

  29. Facilitators

    Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by observation

    Measured: Assessed during the 24 month study period

  30. Facilitators

    Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by documentation.

    Measured: Assessed during the 24 month study period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2017
  2. Study start12 Sep 2017
  3. Primary completion30 Oct 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
732 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03322839
Sponsor's protocol ID
150571
Other IDs
150571
Status last verified
Sep 2020
First submitted
19 Sep 2017
Last updated
14 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The ethical approval does not allow data-sharing of individual participation data.

Publications

  • Kwak L, Lornudd C, Bjorklund C, Bergstrom G, Nybergh L, Elinder LS, Stigmar K, Wahlin C, Jensen I. Implementation of the Swedish Guideline for Prevention of Mental ill-health at the Workplace: study protocol of a cluster randomized controlled trial, using multifaceted implementation strategies in schools. BMC Public Health. 2019 Dec 11;19(1):1668. doi: 10.1186/s12889-019-7976-6.

    PubMed 31829186

Questions about this trial

What is this clinical trial studying?

A study testing Multifaceted implementation strategies and Single implementation strategy in people with Common Mental Disorders, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Guideline adherence (implementation effectiveness) (time frame: At baseline and 6, 12 and 24 months after baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03322839, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in